| Authors | Keiichi Sumida, Yoshifumi Ubara, Fumi Takemoto, Kenmei Takaichi |
| Journal | Clinical and experimental rheumatology
(Clin Exp Rheumatol)
2011 Jan-Feb
Vol. 29
Issue 1 Suppl 64
Pg. S133
ISSN: 0392-856X [Print] Italy |
| PMID | 21385558
(Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents
- Receptors, Interleukin-6
- Tumor Necrosis Factor Inhibitors
- Tumor Necrosis Factors
- Infliximab
- Adalimumab
- tocilizumab
|
| Topics |
- Adalimumab
- Aged
- Antibodies, Monoclonal
(therapeutic use)
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents
(therapeutic use)
- Drug Resistance, Multiple
- Drug Therapy, Combination
- Female
- Humans
- Infliximab
- Receptors, Interleukin-6
(antagonists & inhibitors, immunology)
- Remission Induction
- Rheumatoid Vasculitis
(diagnosis, drug therapy, immunology)
- Treatment Outcome
- Tumor Necrosis Factor Inhibitors
- Tumor Necrosis Factors
(immunology)
|
